Public Employees Retirement System of Ohio Purchases Shares of 293,115 Cellebrite DI Ltd. (NASDAQ:CLBT)

Public Employees Retirement System of Ohio purchased a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 293,115 shares of the company's stock, valued at approximately $4,936,000. Public Employees Retirement System of Ohio owned about 0.14% of Cellebrite DI at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Quarry LP bought a new position in Cellebrite DI in the 3rd quarter valued at about $27,000. Point72 Asia Singapore Pte. Ltd. increased its holdings in shares of Cellebrite DI by 59.6% in the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company's stock worth $33,000 after purchasing an additional 1,017 shares during the period. Advisors Asset Management Inc. raised its holdings in shares of Cellebrite DI by 130.5% in the 3rd quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company's stock valued at $52,000 after acquiring an additional 1,742 shares in the last quarter. Pathway Financial Advisers LLC lifted its position in Cellebrite DI by 1,583.8% during the third quarter. Pathway Financial Advisers LLC now owns 4,378 shares of the company's stock valued at $74,000 after purchasing an additional 4,118 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado bought a new stake in shares of Cellebrite DI during the 2nd quarter worth $71,000. Institutional investors and hedge funds own 45.88% of the company's stock.

Cellebrite DI Trading Down 0.8 %

Shares of NASDAQ CLBT traded down $0.16 during midday trading on Friday, reaching $19.88. The company had a trading volume of 664,188 shares, compared to its average volume of 1,345,583. Cellebrite DI Ltd. has a 1 year low of $7.91 and a 1 year high of $21.72. The stock has a market cap of $4.09 billion, a P/E ratio of -12.83, a P/E/G ratio of 2.71 and a beta of 1.51. The business's 50-day simple moving average is $18.93 and its 200 day simple moving average is $15.78.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last posted its earnings results on Wednesday, November 6th. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.05. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The business had revenue of $106.90 million for the quarter, compared to analyst estimates of $102.06 million. During the same period in the prior year, the company posted $0.09 EPS. The company's revenue for the quarter was up 27.0% on a year-over-year basis. Analysts predict that Cellebrite DI Ltd. will post 0.32 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently weighed in on CLBT shares. JPMorgan Chase & Co. boosted their target price on Cellebrite DI from $21.00 to $22.00 and gave the stock an "overweight" rating in a research report on Thursday, November 7th. TD Cowen upped their price target on shares of Cellebrite DI from $20.00 to $23.00 and gave the stock a "buy" rating in a research note on Monday, September 23rd. Craig Hallum lifted their target price on shares of Cellebrite DI from $23.00 to $24.00 and gave the stock a "buy" rating in a research report on Thursday, November 7th. Finally, Needham & Company LLC raised their price objective on Cellebrite DI from $17.00 to $21.00 and gave the stock a "buy" rating in a research note on Thursday, November 7th. Eight equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Cellebrite DI presently has an average rating of "Buy" and an average target price of $20.29.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.